This cohort study examines prescription medication use and out-of-pocket spending among Indigenous and non-Indigenous Australians after a governmental program to reduce prescription drug co-payments.
This cohort study examines prescription medication use and out-of-pocket spending among Indigenous and non-Indigenous Australians after a governmental program to reduce prescription drug co-payments.
This cohort study estimates long-term personal income losses following hospital diagnosis for selected mental and physical disorders, including depression, alcohol use disorder, stroke, and breast cancer.
This cohort study estimates long-term personal income losses following hospital diagnosis for selected mental and physical disorders, including depression, alcohol use disorder, stroke, and breast cancer.
This cohort study quantifies how many contracts became eligible for quality bonuses due to Categorical Adjustment Index (CAI) adjustments and estimates the association between CAI values, adjusted star ratings, and bonus status in Medicare Advantage contracts between 2014 and 2025.
This cohort study quantifies how many contracts became eligible for quality bonuses due to Categorical Adjustment Index (CAI) adjustments and estimates the association between CAI values, adjusted star ratings, and bonus status in Medicare Advantage contracts between 2014 and 2025.
This Viewpoint discusses the importance of patient and physician lawsuits and how the 2025 US Supreme Court decision Medina v Planned Parenthood South Atlantic may impede access to justice.
This Viewpoint discusses the importance of patient and physician lawsuits and how the 2025 US Supreme Court decision Medina v Planned Parenthood South Atlantic may impede access to justice.
This JAMA Forum discusses the opportunities and challenges facing US Food and Drug Administration (FDA) new approval paths for individualized therapies to treat rare genetic diseases.
This JAMA Forum discusses the opportunities and challenges facing US Food and Drug Administration (FDA) new approval paths for individualized therapies to treat rare genetic diseases.
This case-control study assesses the association of losing insurance with diabetes outcomes among people with low income served by community health centers.
This case-control study assesses the association of losing insurance with diabetes outcomes among people with low income served by community health centers.
This economic evaluation examines the descriptive evidence contributing to the shortage of drugs used to treat attention-deficit/hyperactivity disorder in 2022 and 2023.
This economic evaluation examines the descriptive evidence contributing to the shortage of drugs used to treat attention-deficit/hyperactivity disorder in 2022 and 2023.
This Viewpoint discusses US federal budget decisions to eliminate funding for nursing education while recruitment programs continue, leading to an emphasis on addressing immediate needs rather than long-term workforce sustainability.
This Viewpoint discusses US federal budget decisions to eliminate funding for nursing education while recruitment programs continue, leading to an emphasis on addressing immediate needs rather than long-term workforce sustainability.
This JAMA Forum discusses the design of an artificial intelligence (AI) prescription pilot program being deployed in Utah, methods for assessing system performance, and the future of the program.
This JAMA Forum discusses the design of an artificial intelligence (AI) prescription pilot program being deployed in Utah, methods for assessing system performance, and the future of the program.
This cross-sectional study assesses the use of Medicareβs Annual Wellness Visits among older patients with Medicare Advantage and traditional Medicare coverage.
This cross-sectional study assesses the use of Medicareβs Annual Wellness Visits among older patients with Medicare Advantage and traditional Medicare coverage.